Introduction
We are doctors looking after patients with blood disorders and scientists studying blood conditions in the lab. Our aim is to deliver the best expert and compassionate care for patients with blood diseases and patients who need blood cell transfusions. We want to reduce the burden of disease now and in the future, through our research, services, education, outreach and advocacy.
Our group includes international, scientific and clinical leaders. We draw on our combined expertise to carry out research and develop new services. Through our work we aim to:
- Improve the cost-effectiveness of cancer therapies and the outcomes of treatment – by developing new single cell approaches which tailor treatments to individuals. Find out more
- Improve the management of common and rare anaemias – by studying the role of iron and inflammation in anaemic patients, especially those who are elderly, and by developing a new national NHS service for patients with rare inherited red cell disorders. Find out more
- Improve the outcomes of blood cell and blood component transfusions – by using advanced e-tools and carrying out clinical trials to find out what approaches work best. Find out more
- Involve patients and carers in the key steps of our research projects. Find out more
Related websites
Oxford Centre for Haematology website: rdm.ox.ac.uk/och
RDM – HaemBio Biobank pages:
rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/och/haembio
NSSG website: nssg.oxford-haematology.org.uk
Introductory Talk by Haematology and Stem Cells Theme Lead Professor Paresh Vyas
Follow the Oxford Centre for Haematology on Twitter
The annual Excellent Supervision Awards, which this year go to @DrAJLewandowski and the @MRC_WIMM's Adam Mead. Many congratulations to the two Adams, and read more about what their students had to say about them: https://t.co/VC5X1p7VcA
Congratulations to Dr. John Dick on receiving the 2020 Pezcoller Foundation-@AACR International Award for Extraordinary Achievement in Cancer Research.
Read more here: https://t.co/rjorEAhNxI https://t.co/1vdNnpQQyH
Happy to see this published- the result of a wonderful collaboration with @adamdesmith. Thanks to @bloodwise_uk and #UKChildhoodLeukaemiaCellBank
Blood Advances on Twitter
“Stimulus Report: Germline variants in predisposition genes in children with Down syndrome and #ALL #leusm https://t.co/ZbuvWINqAJ”
twitter.com
Congratulations Professor Trumpp!
German Cancer Prize Awarded to Andreas Trumpp https://t.co/iwKHTjalKD
MUHIMBILI YAZINDUA UTAFIKi KUBAINI SARATANI KWA KUTUMIA TEKNOLOJIA YA KISASA Launch of NIHR-RIGHT programme AI-REAL:speed up diagnosis of children with lymphomas: @muhimbiliuniver @unioxford1 @OxfordOncology @OxfordHaem
MUHIMBILI BLOG : MUHIMBILI YAZINDUA UTAFITI KUBAINI SARATANI KWA KUTUMIA TEKNOLOJIA YA KISASA
Hospitali ya Taifa Muhimbili (MNH) imezindua mradi wa utafiti unalenga kuboresha utambuzi na matibabu ya saratani za damu kwa watoto ambao utashirik
www.mnh.or.tz
Erythroblasts enucleating their way through Valentine’s Day ❣️
